Siloton specialises in miniaturised optical technology for medical imaging, using photonic chips and OCT to detect and monitor major diseases like macular degeneration, glaucoma, diabetes, MS, and certain cancers.
At Siloton, we are experts in miniaturising optics for medical applications, using photonic chip technology.
Our products are designed around an imaging technique called Optical Coherence Tomography (OCT), which is widely used for detecting and monitoring some of the world’s most prevalent diseases, including age-related macular degeneration and glaucoma.
It can also pick up on conditions such as multiple sclerosis, diabetes, and certain types of cancers.
Are you developing a new OCT product that could benefit from the advantages photonic chips have to offer?
Siloton’s OCT-Chip Development Kits allow you to rapidly evaluate the technology and de-risk its adoption. Leasing a development kit also gives you priority access to our next generation of device.
Looking for a slightly different wavelength or additional functionality? Our Feasibility & Customisation packages tweak our off-the-shelf products to work for you.
Coming Soon – Siloton’s very own Ophthalmic OCT System, powered by the same technology as our development kits.
Siloton secures first European patent
Siloton ships world’s first quantum photonic-chip-OCT system
Siloton ships world’s first quantum photonic-chip-OCT system
Applications open for a (senior) integrated photonics engineer to join the Siloton team
